NEW YORK (GenomeWeb News) - Bio-Rad said today that it has purchased the medical diagnostics business of Provalis for around $3 million in cash.
 
Provalis’ diagnostics business, based in the UK, sells point-of-care diagnostic products for chronic disease management of diabetes and osteoporosis. The unit’s principal products are the in2it A1c and Glycosal diagnostic tests for diabetes.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.